The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia
Open accessAbstract
Immobility induced by forced swimming is well known as an animal model of depression. To develop an animal model for the negative symptoms of schizophrenia, in particular the depressive symptoms, the effect of phencyclidine (PCP) on immobility in the forced swimming test was investigated in mice, since PCP produces such negative symptoms in humans. Repeated treatment with PCP (10 mg kg−1 day−1, s.c., once a day for 14 days) prolonged the immobility time in the forced swimming test 24 h after the final injection compared with saline treatment; the effect was not obtained by single or 5 treatments with PCP (10 mg kg−1, s.c.), or by repeated treatment with methamphetamine (0.5 and 1 mg kg−1 day−1, s.c., once a day for 14 days). The enhancing effect of PCP (10 mg kg−1 day−1, s.c.) on the immobility persisted for at least 21 days after the withdrawal of the drug. Haloperidol (0.3 and mg kg−1, p.o.), ritanserin (3 and 10 mg kg−1, p.o.), risperidone (0.1‐1 mg kg−, p.o.), and clozapine (3 and 10 mg kg−1, p.o.) failed to attenuate the immobility induced by the forced swimming in mice repeatedly treated with saline when the drugs were administered 1 h before the forced swimming test. However, ritanserin (30 mg kg−1) and clozapine (30 mg kg−1) did attenuate this immobility. The enhancing effect of PCP on the immobility was attenuated by ritanserin (3 and 10 mg kg−1, p.o.), risperidone (0.3 mg kg−1, p.o.), and clozapine (3 and 10 mg kg−1, p.o.), whereas haloperidol (0.3 and 1 mg kg−1, p.o.) had no effect. These results suggest that the enhancement of immobility in the forced swimming test brought about by repeated PCP treatment could be used as a model of the negative symptoms, particularly the depression, of schizophrenia. This effect of PCP appeared to be mediated, at least in part, via 5‐HT 2 A receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Katz, R. J., Roth, K. A., & Carroll, B. J. (1981) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(81)90005-1 · Cited by 889
Lipska, B. K., Jaskiw, G. E., & Weinberger, D. R. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.44 · Cited by 697
Cited by
Regulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan, T. P., Chambers, R. A., & Russell, D. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.009 · Cited by 514
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391
Motor Symptoms and Schizophrenia
Walther, S., & Strik, W. (2012) · Neuropsychobiology · doi:10.1159/000339456 · Cited by 369
Oike, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.387 · Cited by 305
Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
Kehrer, C. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.006.2008 · Cited by 287
Metadata
- Authors
- Noda, Y., Yamada, K., Furukawa, H., & Nabeshima, T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1995-11
- Volume
- 116
- Issue
- 5
- Pages
- 2531-2537
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2049728523
- Cited by
- 224
- References
- 5
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. https://app.cochat.ai/papers/10.1111/j.1476-5381.1995.tb15106.x
- The paper
- Noda, Y., Yamada, K., Furukawa, H., & Nabeshima, T. (1995). Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1995.tb15106.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.